Neuralstem, Inc. (CUR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.25-0.00 (-1.88%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.25
Bid0.08 x 3500
Ask0.00 x
Day's Range0.24 - 0.26
52wk Range0.24 - 0.29
1y Target EstN/A
Market Cap28.71M
P/E Ratio (ttm)-1.14
Avg Vol (3m)343,700
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube10 days ago

    ETF’s with exposure to Neuralstem, Inc. : August 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Neuralstem, Inc. Here are 5 ETF’s with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Neuralstem, Inc. :CUR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016
    Capital Cube11 days ago

    Neuralstem, Inc. :CUR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016

    Categories: Yahoo Finance Get free summary analysis Neuralstem, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Neuralstem, Inc. – Titan Pharmaceuticals, Inc., Cytokinetics, Incorporated, Acorda Therapeutics, Inc., Geron Corporation, Albany Molecular Research, Inc., BioTime, Inc., Neurocrine Biosciences, Inc., Charles River Laboratories International, Inc. and Intra-Cellular ... Read more (Read more...)

  • Associated Press18 days ago

    Neuralstem reports 2Q loss

    The Germantown, Maryland-based company said it had a loss of 4 cents per share. The biopharmaceutical company posted revenue of $3,000 in the period. In the final minutes of trading on Thursday, the company's ...